Scarica l'app Stockscreener
2.71
1.45%
-0.04
Dopo l'orario di chiusura:
2.71
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ZNTL Giù?
Forum
Previsione
Precedente Chiudi:
$2.75
Aprire:
$2.86
Volume 24 ore:
396.78K
Relative Volume:
0.31
Capitalizzazione di mercato:
$175.47M
Reddito:
$26.87M
Utile/perdita netta:
$-149.32M
Rapporto P/E:
-1.3008
EPS:
-2.0833
Flusso di cassa netto:
$-134.01M
1 W Prestazione:
+18.08%
1M Prestazione:
+13.39%
6M Prestazione:
+81.88%
1 anno Prestazione:
+49.72%
Intervallo 1D:
$2.66
$2.86
Intervallo di 1 settimana:
$2.25
$3.13
Portata 52W:
$1.01
$3.95
Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile
Nome
Zentalis Pharmaceuticals Inc
Settore
Industria
Telefono
(858) 263-4333
Indirizzo
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
Compare ZNTL vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZNTL
Zentalis Pharmaceuticals Inc
|
2.71 | 175.47M | 26.87M | -149.32M | -134.01M | -2.0833 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-12 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2024-06-20 | Downgrade | UBS | Buy → Neutral |
| 2024-06-18 | Downgrade | Jefferies | Buy → Hold |
| 2024-06-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-18 | Downgrade | Wedbush | Neutral → Underperform |
| 2024-06-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-11-08 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2022-07-12 | Iniziato | Cowen | Outperform |
| 2022-04-06 | Iniziato | Wells Fargo | Overweight |
| 2021-10-07 | Ripresa | Jefferies | Buy |
| 2021-09-30 | Iniziato | Stifel | Buy |
| 2021-09-29 | Iniziato | Oppenheimer | Outperform |
| 2021-05-21 | Iniziato | UBS | Buy |
| 2021-01-20 | Iniziato | Wedbush | Outperform |
| 2020-09-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-08-27 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-28 | Iniziato | Guggenheim | Buy |
| 2020-04-28 | Iniziato | Jefferies | Buy |
| 2020-04-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-04-28 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Zentalis Pharmaceuticals Inc Borsa (ZNTL) Ultime notizie
Squadron reports 3,676,900-share stake in Zentalis (ZNTL) - Stock Titan
Aug PreEarnings: What is the implied volatility of BlackRock Municipal Income TrustQuarterly Portfolio Review & Safe Capital Growth Tips - baoquankhu1.vn
Loss Report: Is Alector Inc a strong growth stock2025 Macro Impact & AI Driven Price Forecasts - baoquankhu1.vn
ZNTL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of "Hold" from Analysts - MarketBeat
Is Zentalis Pharmaceuticals Inc. likely to announce a buybackMarket Activity Recap & Trade Opportunity Analysis - mfd.ru
Rate Cut: Can Zentalis Pharmaceuticals Inc. expand its profit marginsBear Alert & Proven Capital Preservation Methods - mfd.ru
Layoff Watch: Can Zentalis Pharmaceuticals Inc keep up with sector leadersMarket Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - Bitget
Aug PostEarnings: Is ASTS stock heavily shortedJuly 2025 PreEarnings & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Zentalis Pharmaceuticals Details Azenosertib Path to PROC Approval, DENALI Dose Pick Coming Soon - Defense World
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Short Interest Update - MarketBeat
Is Zentalis Pharmaceuticals Inc. forming a double bottomTrade Risk Assessment & Stepwise Swing Trade Plans - mfd.ru
Can Zentalis Pharmaceuticals Inc. stock sustain institutional interestDollar Strength & Daily Entry Point Trade Alerts - mfd.ru
Is Zentalis Pharmaceuticals Inc. currently under institutional pressure2025 Volume Leaders & Risk Controlled Daily Trade Plans - mfd.ru
Don't Ignore The Insider Selling In Zentalis Pharmaceuticals - simplywall.st
Have Zentalis Pharmaceuticals Insiders Been Selling Stock? - 富途牛牛
Vincent Vultaggio Sells 29,951 Shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL) Stock - MarketBeat
Zentalis Pharmaceuticals PAO sells shares worth $97,556 By Investing.com - Investing.com Canada
Zentalis Pharma CMO Bruns sells $7998 in stock By Investing.com - Investing.com Canada
Zentalis Pharma CEO Eastland sells $21k in shares By Investing.com - Investing.com Canada
Zentalis Pharmaceuticals PAO sells shares worth $97,556 - Investing.com
Will Zentalis Pharmaceuticals Inc. be affected by tariffsJuly 2025 Reactions & Fast Exit Strategy with Risk Control - mfd.ru
Zentalis Pharmaceuticals, Inc. $ZNTL Shares Sold by Tybourne Capital Management HK Ltd. - MarketBeat
Zentalis Pharmaceuticals PAO sells $7.8k in stock - Investing.com South Africa
Zentalis Pharmaceuticals PAO sells $7.8k in stock By Investing.com - Investing.com Nigeria
Will Zentalis Pharmaceuticals Inc be affected by tariffsQuarterly Trade Review & Daily Technical Forecast Reports - baoquankhu1.vn
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conference - GlobeNewswire
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Stock Report: Is Zentalis Pharmaceuticals Inc currently under institutional pressureDay Trade & Smart Swing Trading Alerts - baoquankhu1.vn
Dow Update: How Zentalis Pharmaceuticals Inc stock reacts to job market data2025 Technical Patterns & Verified Swing Trading Watchlist - Bộ Nội Vụ
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026 - Benzinga
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026 - Sahm
After-Hours Rally: Zentalis, LifeMD, And NanoViricides Among Top Gainers - Nasdaq
A Look At Zentalis Pharmaceuticals (ZNTL) Valuation After Azenosertib Progress And Insider Buying - Yahoo Finance
Zentalis Pharma Advances Stir Market as Azenosertib Program Strengthens - timothysykes.com
Zentalis outlines 2026 milestones for azenosertib program - The Globe and Mail
Zentalis Pharmaceuticals Surges After Promising Azenosertib Developments - StocksToTrade
Trade Recap: Will Zentalis Pharmaceuticals Inc stock outperform tech sector in 20252025 Performance Recap & Long-Term Safe Investment Plans - Bộ Nội Vụ
Zentalis Pharmaceuticals Surges with Azenosertib Developments - timothysykes.com
Zentalis Pharmaceuticals, Inc. Provides Corporate Update on Azenosertib Development - TradingView — Track All Markets
Azenosertib plans at Zentalis (NASDAQ: ZNTL) with cash runway to 2027 - Stock Titan
Zentalis Pharmaceuticals Stock (ZNTL) Opinions on Azenosertib Development Update - Quiver Quantitative
Aug Weekly: Is Zentalis Pharmaceuticals Inc. stock ready for breakoutPortfolio Update Summary & Trade Opportunity Analysis Reports - ulpravda.ru
Major Investor Makes Bold Move on Zentalis Pharmaceuticals Stock - TipRanks
Is Zentalis Pharmaceuticals Inc. stock ready for breakoutGap Up & Low Risk Profit Maximizing Plans - Улправда
Insider Buying: Zentalis Pharmaceuticals (NASDAQ:ZNTL) Major Shareholder Purchases 6,459,973 Shares of Stock - MarketBeat
Walters group buys Zentalis Pharmaceuticals (ZNTL) shares for $7.7m By Investing.com - Investing.com Nigeria
Zentalis Pharmaceuticals Inc Azioni (ZNTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):